Jump to content

Nerelimomab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by InternetArchiveBot (talk | contribs) at 05:35, 16 April 2020 (Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Nerelimomab
Monoclonal antibody
TypeWhole antibody
SourceMouse
TargetTNF alpha
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
 ☒NcheckY (what is this?)  (verify)

Nerelimomab is a mouse monoclonal antibody acting as a TNF inhibitor.[1]

References

  1. ^ "WHO Drug Information" (PDF). Archived from the original (PDF) on 2012-02-19. Retrieved 2009-09-24.